Akebia Therapeutics's current assets is $240M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), AKBA shows a current assets of $240M. That compares with $200M in the prior-year period — up 19.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, AKBA's current assets is now $240M (was $200M) — a 19.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Akebia Therapeutics is outperforming or lagging.
Tracking AKBA's current assets over time shows whether Akebia Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $240M That compares with $200M in the prior-year period — up 19.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current assets page, Stockcircle has Akebia Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $240M) with ownership activity and broader fundamentals.
Akebia Therapeutics's current assets is $240M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.